Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Operating Income
Mayinglong Pharmaceutical Group Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Operating Income
¥456.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Income
¥7.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income?
Operating Income
456.9m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Operating Income amounts to 456.9m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%
Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 7% over the past three years , 8% over the past five years , and 10% over the past ten years .